Table 2.
Univariate and multivariable analysis of the risk factor for CRKP in the patients with KP in the HM department.
| Characteristics | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|
| OR (95%CI) | p-value | OR (95%CI) | p-value | |
| HSCT recipients | ||||
| No | Ref. | |||
| Yes | 0.42 (0.19–0.94) | 0.073 | 0.36 (0.13–0.96) | 0.042 |
| Prior ICU stay | ||||
| No | Ref. | Ref. | ||
| Yes | 19.98 (3.97–100.69) | <0.001 | 26.78 (3.08–233.09) | 0.003 |
| Venous catheter | ||||
| No | Ref. | Ref. | ||
| Yes | 2.49 (0.99–6.30) | 0.075 | 2.73 (0.85–8.71) | 0.091 |
| Carbapenems | ||||
| No | Ref. | Ref. | ||
| Yes | 3.67 (1.77–7.62) | 0.001 | 2.89 (1.22–6.83) | 0.016 |
HSCT, hematopoietic stem cell transplant; ICU, intensive care unit; Ref, reference; OR, odds ratio; CI, confident interval; KP, Klebsiella pneumoniae; HM, hematological malignancies.